Articles tagged with Patent Law
A new paper argues that FDA-required drug labels should not be used as key evidence in patent cases against generic-drug manufacturers. Instead, clinicians rely on guidelines, experience, and medical literature when making prescribing decisions.
A new study finds that multinational firms approach patent litigation as part of a coordinated global strategy, concentrating lawsuits in jurisdictions with similar legal outcomes. When outcomes diverge, firms diversify their litigation locations to manage uncertainty and risk.
Four UTA faculty members - Cameron, Dias, Shiakolas, and Yuan - recognized by the National Academy of Inventors for their outstanding research discoveries. Their innovations have made a tangible impact on society through patents, licensing, and commercialization.
The Terasaki Institute for Biomedical Innovation has announced the recipients of its inaugural Keith Terasaki Mid-Career Innovation Award. Dr. Liangfang Zhang and Dr. Aydogan Ozcan were recognized for their innovative approaches to translating groundbreaking research into real-world impact.
Omid Veiseh, a Rice University bioengineer, has been elected as a National Academy of Inventors Fellow for his significant contributions to innovation and society's welfare. He holds over 5,000 issued US patents and has demonstrated leadership in biotechnology.
New research from Texas McCombs found that startups have an outsized number of future citations, sparking more innovation in emerging industries like photovoltaic cells. Startups' inventions are more likely to be cited by universities and companies due to resource disparities, academic citations, and prior lawsuits.
A study of Medicare claims data found that higher segregation of hospital care is associated with poorer health outcomes for both Black and white patients. Policymakers can address this issue through payment reform efforts and expansion of health insurance coverage to reduce racial disparities in healthcare.
Researchers created a database linking utility patents and NIH funding to assess translational efficiency. The Translational Ratio metric provides insights into patenting efficiency and its impact on drug innovation and treatment development. Institutions with strong engineering operations tend to be more successful in producing patents.
Patent thickets and evergreening strategies hinder generic competition, leading to higher brand name drug prices. Generic entry can drop prices by 90%, affecting patient welfare. Patent expert Sean Tu advocates for a balanced patent system that promotes innovation while preventing monopolies.
A new study co-authored by Bayes Business School found that larger public companies suffer from loss of innovation and lower share price value when managers are permitted to take decisions in their own self-interest. The study examined the effects of waiving fiduciary duties on R&D investment, finding a significant decline.
Academics argue AI systems like DABUS need new IP laws as existing ones are inadequate to deal with cases where machines are named sole inventors. The authors recommend introducing a new 'AI-IP' form of law that would be specifically tailored to AI-generated inventiveness, addressing ownership and novelty issues.
A new model of generic entry and patent litigation recommends a system that rewards the first successful challenger, resulting in fewer pay-for-delay deals. The researchers also advise limiting branded firms' ability to launch authorized generics to prevent such agreements.
Prophetic patents often describe hypothetical experiments with excessive detail, potentially misleading scientists and non-experts. Labels are suggested to distinguish between prophetic and non-prophetic examples in patent applications.
The new SimVis visual simulator, developed by CSIC researchers, enables patients to experiment how their vision will improve before surgery. The technology offers a realistic experience and can be wirelessly controlled via mobile application or tablet.
Two UT Austin engineers, Hal Alper and Alex Huang, have been selected as fellows in the prestigious National Academy of Inventors. Their research has led to significant innovations in biochemical engineering and power semiconductor device technology, resulting in seven U.S.-issued patents and technologies licensed to several companies.
A recent study published in Science reveals that patent trolls are suing firms regardless of actual patent infringement, leading to a negative impact on research and development investment. The authors propose advance review procedures to screen out trolling and encourage legitimate infringement claims.
A new paper from Rice University's Baker Institute calls for revised patenting guidelines to address the broad patent landscape in biotechnology. The authors suggest initial steps to reform patent licensing and require detailed patent descriptions to prevent costly lawsuits.
A new public resource, The Lens, brings transparency to gene patenting by analyzing over 120 million DNA sequences and 10 million protein sequences from global patent documents. Researchers can explore who has sought patents on genes and proteins in any organism, promoting a transparent and fair society.
A University of Michigan Medical School physician and medical historian argues that the 30-year-old Bayh-Dole law needs revision to prioritize public benefit over profits. The law's haphazard history and modern risks, including patenting human genes, warrant a rational dialogue about revising it.
A new study by the University of East Anglia reveals that pay-to-delay deals can lead to significantly higher prices for generic versions of drugs, harming consumer welfare and health services. The research suggests that moves to investigate and ban such agreements are justified due to anti-competitive practices.
IDIBELL has licensed a patent for a repositioned drug to treat X-linked adrenoleukodystrophy, a rare neurodegenerative disease. The patented product has shown promise in laboratory studies, but further research is needed before its application can be considered.
Researchers at IDIBELL and VHIR have developed a treatment using adult mesenchymal stem cells to regenerate damaged lung tissue and reduce inflammation. The licensed product has shown promising results in animal models of acute respiratory distress and allergic asthma.
A recent study reveals that 41% of the human genome is covered by longer DNA patents, which could lead to a loss of individual genomic liberty. The study also found that short sequences from patents cover virtually the entire genome, even outside of genes.
Researchers warn that pending cases threaten public health in India, highlighting legal challenges to key provisions of the Patents Act. The report argues that the country's patent laws can help improve access to medicines if properly applied.
The USPTO has implemented the America Invents Act, a significant reform of US patent law, allowing for public input and feedback throughout the rulemaking process. The act introduces a new framework for patents, with a focus on balance and collaboration between the agency and various stakeholders.
Researchers suggest enhanced public funding, partnerships, and open-source consortia may improve biomarker discovery and development. The Supreme Court's move to free medical diagnosis from private ownership could enhance public health.
The current system is broken due to complex rules and regulations leading to costly litigation between brand and generic companies. Reform options include a standard fixed period for market exclusivity or abolishing the Patented Medicines regulations, both aimed at reducing litigation and improving investment certainty.
Research reveals that technology companies are targeting the US International Trade Commission (ITC) over federal district courts for smart-phone patent disputes due to its speed and expertise. The ITC's specialization in patent issues and streamlined procedure make it an attractive option for companies seeking a quick decision.
Exclusive licenses to gene patents hinder competition and innovation in genetic testing, according to researchers at the Duke Institute for Genome Sciences & Policy. The findings suggest that overly broad patent claims are the primary issue, rather than patents themselves.
Researchers from Duke University found that exclusive patents in gene testing slow promising new technologies and business models. The studies examined genetic risk testing for 10 clinical conditions, including breast and colon cancer.
DynaDx has released the Multimodal Pressure-Flow technique, which incorporates NASA's Hilbert-Huang Transform technology to analyze cerebral autoregulation. This allows for fast and reliable results in diagnosing conditions such as traumatic brain injury and hypertension.
The development of new pharmaceuticals is being stifled by patent challenges that increase generic competition, according to researchers. The number of new compounds approved annually has fallen, and the effective life of key patents will continue to decline, leading to revenue declines in the industry.
NASA sold a portfolio of 11 patented technologies, including the Hilbert-Huang Transform method, to Ocean Tomo Federal Services LLC through a public auction. The sale demonstrated the government's ability to commercialize federally-funded technology and accelerate innovation.
A Portland researcher argues that overly restrictive intellectual property laws slow the availability of existing medications as life-saving treatments. Berger suggests that 'use' patents involving new uses for old medications need to be reformed to encourage pharmaceutical companies to develop these drugs.
The new USGENE database provides unparalleled resources for biosequence patents, offering advanced sequence searching methods and comprehensive search options. FIZ Karlsruhe partners with SequenceBase Corporation to offer the first access to this new database on STN International.
Patent law enables broad adoption of biomedical innovations by reducing transaction costs associated with negotiation and enforcement. Breaking patents can lead to monopolization and hinder competition.
Saneron CCEL, a biotechnology R&D startup, has been awarded a $150,000 grant from the NIH to develop Sertoli cells combined with stem cells for treating spinal cord injuries. The company aims to provide readily available, non-controversial stem cells for cellular therapies.
The new method produces uniformly sized metal nanospheres with improved safety compared to current production technologies. The solution contains a metal compound, water, and a solvent like methanol or ethanol, reducing the risk of fire or explosion.
A group of leading US public sector agricultural research institutions has agreed to share their patented technologies to help improve staple crop varieties like rice, cassava, and sorghum. The Public-Sector Intellectual Property Resource for Agriculture (PIPRA) initiative aims to accelerate research and development to boost the domest...
A new case study highlights the pitfalls of patent infringement, academic secrecy, and lack of government oversight in the commercialization of university research. The Bayh-Dole Act of 1980 is called for changes to promote public good.
William Cohn, a cardiothoracic surgeon at Beth Israel Deaconess Medical Center, has invented the Cohn Cardiac Stabilizer, allowing coronary artery bypass surgery to be performed on a beating heart. The device has advanced the state of the art and will speed patient recovery and save lives.
Roy Curtiss III's patent covers a genetically engineered bacterial antigen delivery system that induces immune responses against foreign antigens. The technology is being used to develop recombinant vaccines for various pathogens, including Heliobacter pylori and Mycobacterium tuberculosis.
The Patent and License Exchange will facilitate safe and efficient transfer of quality patents and licenses through a sophisticated searchable database, transparent pricing model, and new patent insurance products. The company aims to reduce the cash value lost due to inefficient patent markets, estimated at over $500 million annually.
Experts address roadblocks in university-industry technology transfer and propose solutions to capture lost billions annually due to inefficient patent and license processes. The panel discussion features prominent figures from leading institutions, including Caltech and UCLA.
A Kansas State University researcher has invented a method for preparing a pre-formed emulsifier that reduces the calorie count of cakes by up to 50%. The emulsifier allows bakers to create low-calorie cake batter with high-quality cakes. By controlling ingredient proportions, bakers can achieve a desired structure and texture.
Two new 'cool climate' grape varieties, Traminette and Marquis, have been bred for their excellent fruit quality and cold-hardiness, making them suitable for the Northeast's short growing seasons. These hybrid grapes have shown promise in trials across several regions.